Shortwave infrared fluorescence imaging with the clinically approved near-infrared dye indocyanine green.
Ontology highlight
ABSTRACT: Fluorescence imaging is a method of real-time molecular tracking in vivo that has enabled many clinical technologies. Imaging in the shortwave IR (SWIR; 1,000-2,000 nm) promises higher contrast, sensitivity, and penetration depths compared with conventional visible and near-IR (NIR) fluorescence imaging. However, adoption of SWIR imaging in clinical settings has been limited, partially due to the absence of US Food and Drug Administration (FDA)-approved fluorophores with peak emission in the SWIR. Here, we show that commercially available NIR dyes, including the FDA-approved contrast agent indocyanine green (ICG), exhibit optical properties suitable for in vivo SWIR fluorescence imaging. Even though their emission spectra peak in the NIR, these dyes outperform commercial SWIR fluorophores
SUBMITTER: Carr JA
PROVIDER: S-EPMC5924901 | biostudies-literature | 2018 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA